Abstract
Marfan syndrome is an inherited disorder characterized by genetic abnormality of microfibrillar connective tissue proteins. Endothelial dysfunction is thought to cause aortic dilation in subjects with a bicuspid aortic valve; however, the role of endothelial dysfunction and endothelial damaging factors has not been elucidated in Marfan syndrome. Flow-mediated dilation, a noninvasive measurement of endothelial function, was evaluated in 39 patients with Marfan syndrome. Aortic diameter was measured at the aortic annulus, aortic root at the sinus of Valsalva, sinotubular junction and ascending aorta by echocardiography, and adjusted for body surface area (BSA). The mean value of flow-mediated dilation was 6.5 ± 2.4 %. Flow-mediated dilation had a negative correlation with the diameter of the ascending thoracic aorta (AscAd)/BSA (R = −0.39, p = 0.020) and multivariate analysis revealed that flow-mediated dilation was an independent factor predicting AscAd/BSA, whereas other segments of the aorta had no association. Furthermore, Brinkman index had a somewhat greater influence on flow-mediated dilation (R = −0.42, p = 0.008). Although subjects who smoked tended to have a larger AscAd compared with non-smokers (AscA/BSA: 17.3 ± 1.8 versus 15.2 ± 3.0 mm/m2, p = 0.013), there was no significant change in flow-mediated dilation, suggesting that smoking might affect aortic dilation via an independent pathway. Common atherogenic risks, such as impairment of flow-mediated dilation and smoking status, affected aortic dilation in subjects with Marfan syndrome.
Similar content being viewed by others
References
Judge DP, Dietz HC (2005) Marfan’s syndrome. Lancet 366:1965–1976
Hirata K, Triposkiadis F, Sparks E, Bowen J, Wooley CF, Boudoulas H (1991) The Marfan syndrome: abnormal aortic elastic properties. J Am Coll Cardiol 18:57–63
Legget ME, Unger TA, O’Sullivan CK, Zwink TR, Bennett RL, Byers PH, Otto CM (1996) Aortic root complications in Marfan’s syndrome: identification of a lower risk group. Heart 75:389–395
Nollen GJ, Groenink M, Tijssen JG, Van Der Wall EE, Mulder BJ (2004) Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J 25:1146–1152
Seals DR, Jablonski KL, Donato AJ (2011) Aging and vascular endothelial function in humans. Clin Sci (Lond) 120:357–375
Lee TC, Zhao YD, Courtman DW, Stewart DJ (2000) Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 101:2345–2348
Aicher D, Urbich C, Zeiher A, Dimmeler S, Schafers HJ (2007) Endothelial nitric oxide synthase in bicuspid aortic valve disease. Ann Thorac Surg 83:1290–1294
De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417–426
Jondeau G, Boutouyrie P, Lacolley P, Laloux B, Dubourg O, Bourdarias JP, Laurent S (1999) Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. Circulation 99:2677–2681
Magda SL, Ciobanu AO, Florescu M, Vinereanu D (2013) Comparative reproducibility of the noninvasive ultrasound methods for the assessment of vascular function. Heart Vessels 28:143–150
Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265
Kilickesmez KO, Abaci O, Kocas C, Yildiz A, Kaya A, Okcun B, Kucukoglu S (2012) Dilatation of the ascending aorta and serum alpha 1-antitrypsin level in patients with bicuspid aortic valve. Heart Vessels 27:391–397
LeMaire SA, Carter SA, Volguina IV, Laux AT, Milewicz DM, Borsato GW, Cheung CK, Bozinovski J, Markesino JM, Vaughn WK, Coselli JS (2006) Spectrum of aortic operations in 300 patients with confirmed or suspected Marfan syndrome. Ann Thorac Surg 81:2063–2078
Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Sicks JD, Fought AJ, O’Fallon WM, Wiebers DO, Tajik AJ (2003) Is aortic dilatation an atherosclerosis-related process? Clinical, laboratory, and transesophageal echocardiographic correlates of thoracic aortic dimensions in the population with implications for thoracic aortic aneurysm formation. J Am Coll Cardiol 42:1076–1083
Tzemos N, Lyseggen E, Silversides C, Jamorski M, Tong JH, Harvey P, Floras J, Siu S (2010) Endothelial function, carotid-femoral stiffness, and plasma matrix metalloproteinase-2 in men with bicuspid aortic valve and dilated aorta. J Am Coll Cardiol 55:660–668
Nakamura M, Itoh S, Makita S, Ohira A, Arakawa N, Hiramori K (2000) Peripheral resistance vessel dysfunction in Marfan syndrome. Am Heart J 139:661–666
Wilson DG, Bellamy MF, Ramsey MW, Goodfellow J, Brownlee M, Davies S, Wilson JF, Lewis MJ, Stuart AG (1999) Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. Circulation 99:909–915
Brigdes AB, Gray JR, McLaren M, Tamei H, Belch JJF (1993) Endothelial cell and platelet function in Marfan syndrome. Endothelium 1:203–206
Perlstein TS, Lee RT (2006) Smoking, metalloproteinases, and vascular disease. Arterioscler Thromb Vasc Biol 26:250–256
Chiu JJ, Chien S (2011) Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev 91:327–387
Mohamed SA, Radtke A, Saraei R, Bullerdiek J, Sorani H, Nimzyk R, Karluss A, Sievers HH, Belge G (2012) Locally different endothelial nitric oxide synthase protein levels in ascending aortic aneurysms of bicuspid and tricuspid aortic valve. Cardiol Res Pract 2012:165957
Wilmink TB, Quick CR, Day NE (1999) The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg 30:1099–1105
Gao L, Zhou X, Zhang L, Wen D, Chang Q, Wu Y, Sun L, Hui R (2011) Factors influencing prognosis in patients with Marfan syndrome after aortic surgery. J Cardiothorac Vasc Anesth 25:625–631
Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332:1198–1203
Talukder MA, Johnson WM, Varadharaj S, Lian J, Kearns PN, El-Mahdy MA, Liu X, Zweier JL (2011) Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol 300:H388–H396
Saijonmaa O, Nyman T, Fyhrquist F (2005) Regulation of angiotensin-converting enzyme production by nicotine in human endothelial cells. Am J Physiol Heart Circ Physiol 289:H2000–H2004
Wang S, Zhang C, Zhang M, Liang B, Zhu H, Lee J, Viollet B, **a L, Zhang Y, Zou MH (2012) Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nat Med 18:902–910
Murphy EA, Danna-Lopes D, Sarfati I, Rao SK, Cohen JR (1998) Nicotine-stimulated elastase activity release by neutrophils in patients with abdominal aortic aneurysms. Ann Vasc Surg 12:41–45
Engelfriet PM, Drenthen W, Pieper PG, Tijssen JG, Yap SC, Boersma E, Mulder BJM (2008) Smoking and its effects on mortality in adults with congenital heart disease. Int J Cardiol 127:93–97
Yetman AT, McCrindle BW (2010) The prevalence and clinical impact of obesity in adults with Marfan syndrome. Can J Cardiol 26:137–139
McLoughlin D, McGuinness J, Byrne J, Terzo E, Huuskonen V, McAllister H, Black A, Kearney S, Kay E, Hill ADK, Dietz HC, Redmond JM (2011) Pravastatin reduces Marfan aortic dilation. Circulation 124:S168–S173
Acknowledgments
This research was supported by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) program.
Conflict of interest
The authors declare no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
M. Takata and E. Amiya contributed equally to this work.
Rights and permissions
About this article
Cite this article
Takata, M., Amiya, E., Watanabe, M. et al. Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndrome. Heart Vessels 29, 478–485 (2014). https://doi.org/10.1007/s00380-013-0393-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-013-0393-3